ENTRY       D10366                      Drug
NAME        Sofosbuvir (JAN/USAN/INN);
            Sovaldi (TN)
  ABBR      SOF
PRODUCT     SOVALDI (Gilead Sciences)
FORMULA     C22H29FN3O9P
EXACT_MASS  529.1625
MOL_WEIGHT  529.4525
CLASS       Antiviral
             DG03198  Anti-HCV agent
              DG02000  HCV NS5B polymerase inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
REMARK      ATC code: J05AP08
            Product: D10366<US>
            Product (mixture): D10578<JP/US> D10827<JP/US> D10900<US>
EFFICACY    Antiviral, NS5B polymerase inhibitor
  DISEASE   Chronic hepatitis C virus infection [DS:H00413]
TARGET      HCV NS5B polymerase [KO:K22472]
  PATHWAY   ko03230(K22472)  Viral genome structure
            ko03240(K22472)  Viral replication
            ko05160(K22472)  Hepatitis C
METABOLISM  Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AP Antivirals for treatment of HCV infections
                 J05AP08 Sofosbuvir
                  D10366  Sofosbuvir (JAN/USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-hepatitis C (HCV) Agents
               Sofosbuvir
                D10366  Sofosbuvir (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG03198  Anti-HCV agent
               DG02000  HCV NS5B polymerase inhibitor
                D10366  Sofosbuvir
             Transporter substrate
              DG01665  ABCB1 substrate
               D10366  Sofosbuvir
              DG01913  ABCG2 substrate
               D10366  Sofosbuvir
            Drug classes [BR:br08332]
             Antiviral
              DG03198  Anti-HCV agent
               D10366  Sofosbuvir
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HCV NS5A/NS5B inhibitor
                D10366  Sofosbuvir (JAN/USAN/INN) &lt;US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HCV NS5A/NS5B inhibitor
                D10366  Sofosbuvir (JAN/USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10366
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10366
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10366
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10366
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D10366
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D10366
DBLINKS     CAS: 1190307-88-0
            PubChem: 172232459
            ChEBI: 85083
            PDB-CCD: WG6
ATOM        36
            1   C1a C     9.2183  -16.9828
            2   C1c C    10.4121  -17.6720
            3   O7a O    11.6059  -16.9828
            4   C7a C    12.7996  -17.6720
            5   C1c C    13.9933  -16.9828
            6   N1b N    15.1872  -17.6720
            7   C1a C    10.4121  -19.0502
            8   O6a O    12.7996  -19.0504
            9   C1a C    13.9933  -15.6045
            10  C1y C    20.6947  -17.5762
            11  C1y C    21.1222  -18.9240
            12  C1z C    22.5361  -18.9339
            13  C1y C    22.9826  -17.5921
            14  O2x O    21.8444  -16.7531
            15  P1b P    16.9323  -16.9828
            16  O3b O    15.7425  -16.2958
            17  O2b O    18.1300  -16.2913
            18  C8y C    18.1320  -14.9154
            19  C8x C    19.3096  -14.2375
            20  C8x C    19.3114  -12.8591
            21  C8x C    18.1186  -12.1683
            22  C8x C    16.9410  -12.8461
            23  C8x C    16.9392  -14.2245
            24  O2b O    18.3120  -17.6964
            25  C1b C    19.4866  -16.9441
            26  O1a O    20.3166  -20.0168
            27  C1a C    23.8864  -19.4877
            28  X   F    22.1827  -20.1470
            29  N4y N    24.2889  -17.1603
            30  C8x C    25.4710  -17.8949
            31  C8x C    26.6865  -17.2447
            32  C8y C    26.7312  -15.8671
            33  N4x N    25.5490  -15.1324
            34  C8y C    24.3335  -15.7825
            35  O5x O    27.9599  -15.2099
            36  O5x O    23.1649  -15.0563
BOND        38
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 1
            7     4   8 2
            8     5   9 1 #Down
            9    10  11 1
            10   11  12 1
            11   12  13 1
            12   13  14 1
            13   10  14 1
            14   15  16 2
            15   15  17 1
            16   17  18 1
            17   18  19 2
            18   19  20 1
            19   20  21 2
            20   21  22 1
            21   22  23 2
            22   18  23 1
            23   15  24 1 #Down
            24   24  25 1
            25   10  25 1 #Up
            26   11  26 1 #Down
            27   12  27 1 #Up
            28   12  28 1 #Down
            29   13  29 1 #Up
            30   29  30 1
            31   30  31 2
            32   31  32 1
            33   32  33 1
            34   33  34 1
            35   29  34 1
            36   32  35 2
            37   34  36 2
            38   15   6 1 #Up
///
